{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T01:08:55Z","timestamp":1778461735891,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15917-3","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T08:33:43Z","timestamp":1774773223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A mechanistic study revealing that SLCO1B3 promotes gastric cancer development and metastasis through MAP1S expression downregulation"],"prefix":"10.1186","volume":"26","author":[{"given":"Shihao","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"issue":"3","key":"15917_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F B","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"15917_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70017","author":"M Li","year":"2025","unstructured":"Li M, Cao S, Xu RH. Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades. Cancer Commun (Lond). 2025;n\/a(n\/a) https:\/\/doi.org\/10.1002\/cac2.70017.","journal-title":"Cancer Commun (Lond)"},{"issue":"2","key":"15917_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2024","unstructured":"Diao X, Guo C, Jin Y, et al. Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun (Lond). 2024;45(2):178\u201397. https:\/\/doi.org\/10.1002\/cac2.12627.","journal-title":"Cancer Commun (Lond)"},{"key":"15917_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pharmthera.2018.10.007","volume":"195","author":"S Oswald","year":"2019","unstructured":"Oswald S. Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine. Pharmacol Ther. 2019;195:39\u201353. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.007.","journal-title":"Pharmacol Ther"},{"key":"15917_CR5","doi-asserted-by":"publisher","unstructured":"Hagenbuch B, Stieger B, Locher KP. Organic anion transporting polypeptides: pharmacology, toxicology, structure, and transport mechanisms. Pharmacol Rev. 2025;77(2). https:\/\/doi.org\/10.1016\/j.pharmr.2024.100023.","DOI":"10.1016\/j.pharmr.2024.100023"},{"key":"15917_CR6","doi-asserted-by":"publisher","unstructured":"X Z YC. Transcriptome analysis of healthy and fatty liver revealed that inhibition of SLCO1B3 induces abnormal liver metabolism and lipid synthesis. Poult Sci. 2023;102(11). https:\/\/doi.org\/10.1016\/j.psj.2023.103023.","DOI":"10.1016\/j.psj.2023.103023"},{"issue":"4","key":"15917_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bbrc.2012.01.115","volume":"418","author":"M N","year":"2012","unstructured":"Nagai M, Furihata T, Matsumoto S, Ishii S, Motohashi S, Yoshino I, et al. Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells. Biochem Biophys Res Commun. 2012;418(4):818\u201323. https:\/\/doi.org\/10.1016\/j.bbrc.2012.01.115.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"15917_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/mp3005353","volume":"10","author":"NTKK Er","year":"2013","unstructured":"Thakkar N, Kim K, Jang ER, Han S, Kim K, Kim D, et al. A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells. Mol Pharm. 2013;10(1):406\u201316. https:\/\/doi.org\/10.1021\/mp3005353.","journal-title":"Mol Pharm"},{"key":"15917_CR9","doi-asserted-by":"publisher","unstructured":"Furihata T, Sun Y, Chiba K. Cancer-type organic anion transporting polypeptide 1B3: current knowledge of the gene structure, expression profile, functional implications and future perspectives. Curr Drug Metab. 2015;16(6):474\u201385. https:\/\/doi.org\/10.2174\/1389200216666150812142715.","DOI":"10.2174\/1389200216666150812142715"},{"key":"15917_CR10","doi-asserted-by":"publisher","unstructured":"Zhi L, Zhao L, Zhang X, Liu w, Gao B, Wang F, et al. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging (Milano). 2021;13(18). https:\/\/doi.org\/10.18632\/aging.203502.","DOI":"10.18632\/aging.203502"},{"key":"15917_CR11","doi-asserted-by":"publisher","unstructured":"Sun Y, Harada M, Shimozato O, Souda H, Takiguchi N, Nabeya Y, et al. Cancer-type OATP1B3 mRNA has the potential to become a detection and prognostic biomarker for human colorectal cancer. Biomarkers Med. 2017;11(8). https:\/\/doi.org\/10.2217\/bmm-2017-0098","DOI":"10.2217\/bmm-2017-0098"},{"issue":"1","key":"15917_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41598-020-80152-0","volume":"11","author":"T Tang","year":"2021","unstructured":"Tang T, Wang G, Liu S, et al. Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis. Sci Rep. 2021;11(1):631. https:\/\/doi.org\/10.1038\/s41598-020-80152-0.","journal-title":"Sci Rep"},{"issue":"1","key":"15917_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3892\/or.2020.7839","volume":"45","author":"H Hase","year":"2021","unstructured":"Hase H, Aoki M, Matsumoto K, et al. Cancer type\u2013SLCO1B3 promotes epithelial\u2013mesenchymal transition resulting in the tumour progression of non\u2013small cell lung cancer. Oncol Rep. 2021;45(1):309\u201316. https:\/\/doi.org\/10.3892\/or.2020.7839.","journal-title":"Oncol Rep"},{"issue":"1","key":"15917_CR14","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1038\/s41598-021-90143-4","volume":"11","author":"RH Barbier","year":"2021","unstructured":"Barbier RH, McCrea EM, Lee KY, et al. Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p. Sci Rep. 2021;11(1):10765. https:\/\/doi.org\/10.1038\/s41598-021-90143-4.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"15917_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/carcin\/bgad075","volume":"45","author":"SH Rajanala","year":"2024","unstructured":"Rajanala SH, Plym A, Vaselkiv JB, et al. SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Carcinogenesis. 2024;45(1\u20132):35\u201344. https:\/\/doi.org\/10.1093\/carcin\/bgad075.","journal-title":"Carcinogenesis"},{"issue":"6","key":"15917_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/bcpt.13866","volume":"132","author":"F Deng","year":"2023","unstructured":"Deng F, Laasik M, Salminen L, et al. Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high-grade serous ovarian cancer. Basic Clin Pharmacol Toxicol. 2023;132(6):521\u201331. https:\/\/doi.org\/10.1111\/bcpt.13866.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"15917_CR17","doi-asserted-by":"publisher","unstructured":"Fischer I. Perspective: examining MAP1B structure with an evolutionary perspective. Cytoskelet (hob NJ). Published online July. 2025;10. https:\/\/doi.org\/10.1002\/cm.70000.","DOI":"10.1002\/cm.70000"},{"issue":"4","key":"15917_CR18","doi-asserted-by":"publisher","first-page":"e202406099","DOI":"10.1083\/jcb.202406099","volume":"224","author":"B MacTaggart","year":"2025","unstructured":"MacTaggart B, Wang J, Tang HY, Kashina A. Arginylation of \u237a-tubulin at E77 regulates microtubule dynamics via MAP1S. J Cell Biol. 2025;224(4):e202406099. https:\/\/doi.org\/10.1083\/jcb.202406099.","journal-title":"J Cell Biol"},{"issue":"19","key":"15917_CR19","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1038\/s41388-020-1257-9","volume":"39","author":"W Li","year":"2020","unstructured":"Li W, Dai Y, Shi B, et al. LRPPRC sustains yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas. Oncogene. 2020;39(19):3879\u201392. https:\/\/doi.org\/10.1038\/s41388-020-1257-9.","journal-title":"Oncogene"},{"key":"15917_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/DDDT.S269277","volume":"15","author":"J Wang","year":"2021","unstructured":"Wang J, Zhang X, Yang F, et al. RASSF1A enhances chemosensitivity of NSCLC cells through activating autophagy by regulating MAP1S to inactivate Keap1-Nrf2 pathway. Drug Des Dev Ther. 2021;15:21\u201335. https:\/\/doi.org\/10.2147\/DDDT.S269277.","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"15917_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00428-020-02917-2","volume":"478","author":"F Gallob","year":"2021","unstructured":"Gallob F, Brcic L, Eidenhammer S, Rumpp F, Nerlich A, Popper H. Senescence and autophagy in usual interstitial pneumonia of different etiology. Virchows Arch: Int J Pathol. 2021;478(3):497\u2013506. https:\/\/doi.org\/10.1007\/s00428-020-02917-2.","journal-title":"Virchows Arch: Int J Pathol"},{"key":"15917_CR22","doi-asserted-by":"publisher","first-page":"730089","DOI":"10.3389\/fimmu.2021.730089","volume":"12","author":"X Jia","year":"2021","unstructured":"Jia X, Zhai T, Zhang JA. Circulating exosome involves in the pathogenesis of autoimmune thyroid diseases through immunomodulatory proteins. Front Immunol. 2021;12:730089. https:\/\/doi.org\/10.3389\/fimmu.2021.730089.","journal-title":"Front Immunol"},{"key":"15917_CR23","doi-asserted-by":"publisher","unstructured":"Lee ITL, Shen CH, Tsai FC, Chen CB, Ma KSK. Cancer-derived extracellular vesicles as biomarkers for cutaneous squamous cell carcinoma: a systematic review. Cancers. 2022;14(20). https:\/\/doi.org\/10.3390\/cancers14205098.","DOI":"10.3390\/cancers14205098"},{"key":"15917_CR24","doi-asserted-by":"publisher","unstructured":"Pavli\u010d R, Vidic S, Anko M, Knific T, B\u00fcdefeld T, Marton K, et al. Altered profile of E1-S transporters in endometrial cancer: lower protein levels of ABCG2 and OST\u03b2 and up-regulation of SLCO1B3 expression. Int J Mol Sci. 2021;22(8). https:\/\/doi.org\/10.3390\/ijms22083819.","DOI":"10.3390\/ijms22083819"},{"key":"15917_CR25","doi-asserted-by":"publisher","unstructured":"Xiang J, Su R, Wu S, Zhou L. Construction of a prognostic signature for serous ovarian cancer based on lactate metabolism-related genes. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.967342.","DOI":"10.3389\/fonc.2022.967342"},{"issue":"2","key":"15917_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12094-022-02958-w","volume":"25","author":"XC X Z","year":"2023","unstructured":"Zhang X, Chen X, Liu J, Li Y, Wu J, Chen M, et al. A novel metabolism-related prognostic gene development and validation in gastric cancer. Clin Transl Oncol: Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex. 2023;25(2):447\u201359. https:\/\/doi.org\/10.1007\/s12094-022-02958-w.","journal-title":"Clin Transl Oncol: Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"15917_CR27","doi-asserted-by":"publisher","unstructured":"Haberkorn B, L\u00f6wen D, Meier L, Fromm MF, K\u00f6nig J. Transcriptional regulation of liver-type OATP1B3 (lt-OATP1B3) and cancer-type OATP1B3 (ct-OATP1B3) studied in hepatocyte-derived and colon cancer-derived cell lines. Pharmaceutics. 2023;15(3). https:\/\/doi.org\/10.3390\/pharmaceutics15030738.","DOI":"10.3390\/pharmaceutics15030738"},{"issue":"7","key":"15917_CR28","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.ejca.2012.12.003","volume":"49","author":"A Ramachandran","year":"2013","unstructured":"Ramachandran A, Betts G, Bhana S, Helme G, Blick C, Moller-Levet C, et al. An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3. Eur J Cancer. 2013;49(7):1741\u201351. https:\/\/doi.org\/10.1016\/j.ejca.2012.12.003.","journal-title":"Eur J Cancer"},{"issue":"10","key":"15917_CR30","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.3390\/ijms22105197","volume":"22","author":"AJ Granados-L\u00f3pez","year":"2021","unstructured":"Granados-L\u00f3pez AJ, Manzanares-Acu\u00f1a E, L\u00f3pez-Hern\u00e1ndez Y, et al. UVB inhibits proliferation, cell cycle and induces apoptosis via p53, E2F1 and microtubules system in cervical cancer cell lines. Int J Mol Sci. 2021;22(10):5197. https:\/\/doi.org\/10.3390\/ijms22105197.","journal-title":"Int J Mol Sci"},{"key":"15917_CR31","doi-asserted-by":"publisher","unstructured":"Poursalim M, Shasaltaneh MD, Jafarian V, Salehabadi H. The novel anti-cancer feature of brazzein through activating of hTLR5 by integration of biological evaluation: molecular docking and molecular dynamics simulation. Sci Rep. 2022;12(1). https:\/\/doi.org\/10.1038\/s41598-022-26487-2.","DOI":"10.1038\/s41598-022-26487-2"},{"key":"15917_CR32","doi-asserted-by":"publisher","unstructured":"Guan Y, Li J, Sun B, Xu K, Zhang Y, Ben H, et al. HBx-induced upregulation of MAP1S drives hepatocellular carcinoma proliferation and migration via MAP1S\/smad\/TGF-\u03b21 loop. Int J Biol Macromol. 2024;281(Pt 3). https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136327.","DOI":"10.1016\/j.ijbiomac.2024.136327"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15917-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:22:31Z","timestamp":1778458951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15917-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15917"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15917-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7967187\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2013 Revision) and has been approved by the Ethics Committee of the Affiliated Hospital of Guilin Medical University (Approval No.: 2024YJSLL-113). All human tissue samples used in this study were collected in accordance with relevant national and institutional regulations, and the donors (or their guardians) have signed written consent forms authorising the use of the samples for scientific research. The animal experiments involved in this study have undergone ethical review by the Institutional Animal Care and Use Committee (IACUC) of Guilin Medical University, with approval number GLMU-IACUC-20251089. All animal experiments were conducted in strict accordance with the ethical requirements approved by the IACUC and the 3Rs principle (Replacement, Reduction, Refinement).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"593"}}